Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersPulmonary Disease Physician in Oklahoma City, OK
NPI: 1093701658Primary Practice Location
MERCY HOSPITAL OKLAHOMA CITY, INC
4300 W Memorial Rd, Oklahoma City, OK
Primary Employer
Robert M. Gordon, M.D., P.L.L.C.
peakmdokc.com
HQ Phone
Get M.D. Robert's Phone Numberphone_androidMobile
Get M.D. Robert's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardIL State Medical License
TX State Medical License
OK State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 227 | 252 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 104 | 145 |
| 3 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 94 | 197 |
| 4 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 75 | 75 |
| 5 | 95806Unattended sleep study with recording of heart rate, oxygen, respiratory airflow and effort | 38 | 38 |
From Patient to Provider: How Personal Medical Trauma Can Inform Supervision and Clinical Practice.
Authors: Gordon, Robert M, Grillo, Aria B, Bernal-Fernandez, Natalia S, Groth, Taylor D, McGiffin, Jed N, Hartline, Kenneth D
Journal: J Infant Child Adolesc Psychother
Type III home sleep testing versus pulse oximetry: is the respiratory disturbance index better than the oxygen desaturation index to predict the apnoea-hypopnoea index measured during laboratory polysomnography?
Authors: Daniel Kripke, Lawrence Kline, Arthur Dawson
Publication Date: 2015-06
Lead Sponsor: Eiger BioPharmaceuticals
Intervention / Treatment: DRUG: Placebo Ritonavir, DRUG: Ritonavir, DRUG: Lonafarnib, DRUG: PEG IFN-alfa-2a, DRUG: Placebo Lonafarnib
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Mirikizumab
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo, DRUG: Mirikizumab
